Adults – Communicable Diseases Research

Prevalence and risk factors of depression and anxiety among Chinese adults who received SARS-CoV-2 vaccine – A cross-sectional survey

Article

Published on 2023-03-012023-07-11
Journal: Journal of affective disorders
[Category] COVID19(2023년),

[키워드] Adults Anxiety Depression SARS-CoV-2 vaccination.
[DOI] 10.1016/j.jad.2022.12.077 PMC 바로가기

Factors associated with humoral immune response in older adults who received egg-free influenza vaccine

Observational Study

Published on 2023-01-162023-06-24
Journal: Vaccine
[Category] 신종인플루엔자,

[키워드] Adults Egg-free influenza vaccine Hemagglutination inhibition assay Humoral response influenza.
[DOI] 10.1016/j.vaccine.2022.12.041 PMC 바로가기 [Article Type] Observational Study

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study

건강한 성인에서 이종 및 동종 불활성화 및 아데노바이러스 매개 COVID-19 백신 요법의 안전성 및 면역원성: 전향적 코호트 연구

Article

Published on 2022-12-312022-09-11
Journal: Human vaccines & immunotherapeutics
[Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술,

[키워드] Adults adverse event adverse events Antibody Response AstraZeneca ChAdOx1 ChAdOx1-S circulating variants combinations CoronaVac country COVID-19 COVID-19 vaccine COVID-19 vaccines dose doses Efficacy Evidence evidence of followed by group groups healthy Heterologous heterologous adenoviral vector heterologous vaccine homologous IgA response immune response immune responses immunized immunogenicity inactivated Inactivated vaccine interferon gamma Mild neutralizing activities Neutralizing activity prospective cohort study reactogenicity Receptor-binding domain referred to regimen Safety Serious Adverse Event Serious Adverse Events supply shortage vaccination Vaccine variants variants of concern Viral viral vectored. wild-type
[DOI] 10.1080/21645515.2022.2029111 PMC 바로가기 [Article Type] Article

Using an extended protection motivation theory to explain vaccine hesitancy: a cross-sectional study among Chinese adults

Article

Published on 2022-12-312023-07-08
Journal: Human vaccines & immunotherapeutics
[Category] COVID19(2023년),

[키워드] Adults Behavior protection motivation theory. Vaccine hesitancy
[DOI] 10.1080/21645515.2022.2026136 PMC 바로가기

Immunogenicity and safety of BNT162b2 mRNA vaccine in Chinese adults: A phase 2 randomised clinical trial

Article

Published on 2022-12-012022-10-06
Journal: The Lancet Regional Health - Western Pacific
[Category] 진단,

[키워드] acute respiratory syndrome Administered Adults adverse event AEs age analysis assessment assigned BNT162b2 BNT162b2 mRNA BNT162b2 mRNA vaccine China Chinese clinical trial Complete Completed conducted coronavirus COVID-19 development dose double-blind Efficacy and safety enrolled Follow-up geometric mean titer GMT GMTs Han Chinese healthy immune response immunogenicity immunogenicity endpoint Inc independent individual injection intramuscular Intramuscular injection investigators Laboratory parameters management messenger Messenger RNA Mild moderate mRNA vaccine Neutralising Antibodies neutralising antibody of BNT162b2 participant Participants pharmaceutical Placebo placebo-controlled trial randomisation randomised Randomly reactogenicity receive recipients recruited reduced remained reported resolved Result robust Safety SARS-CoV-2 SARS-CoV-2 variant SCR second dose sera serious AE seroconversion rate severity Shanghai Sponsor statisticians stratified T-cell Response the placebo group Tolerability Treatment Trial utilised vaccination vaccination. vaccine administration were blinded
[DOI] 10.1016/j.lanwpc.2022.100586 PMC 바로가기 [Article Type] Article

Maternal SARS-CoV-2 sero-surveillance using newborn dried blood spot (DBS) screening specimens highlights extent of low vaccine uptake in pregnant women

Article

Published on 2022-11-302022-11-15
Journal: Human vaccines & immunotherapeutics
[Category] COVID19(2023년), SARS, 변종, 진단,

Evaluation of the effect of enhanced immunization in adults: A cross-sectional study in the southeast city of China

Article

Published on 2022-11-302023-06-11
Journal: Human vaccines & immunotherapeutics
[Category] B형 간염,

[키워드] Adults enhanced immunization Hepatitis B virus vaccine.
[DOI] 10.1080/21645515.2022.2096972 PMC 바로가기

Evaluation of mRNA-1273 Vaccine in Children 6 Months to 5 Years of Age

Article

Published on 2022-11-032022-11-15
Journal: The New England Journal of Medicine
[Category] Fulltext, MERS, 변종, 진단,

[키워드] 95% CI 95% confidence interval acute respiratory syndrome Administered administration Adults Adverse age assigned authority B.1.1.529 children circulating Cohort cohorts coronavirus coronavirus disease criteria determine development dose duration of follow-up Efficacy elicited evaluate evaluated event geometric mean concentration immune response incidence Infection injection median Month mRNA-1273 mRNA-1273 vaccine neutralizing antibody observer-blinded open label Part phase 3 trial Placebo placebo-controlled predominant Randomly reactogenicity receive Safe Secondary objective selected the vaccine Trial Vaccine variant Year
[DOI] 10.1056/NEJMoa2209367 PMC 바로가기

Inferring the true number of SARS-CoV-2 infections in Japan

Article

Published on 2022-11-012022-11-16
Journal: Journal of infection and chemotherapy : official j
[Category] SARS, 변종,

[Vaccination against coronavirus disease 2019 (COVID-19)]

Article

Published on 2022-11-012022-11-15
Journal: Zeitschrift Fur Gerontologie Und Geriatrie
[Category] SARS, 변종, 진단,

[키워드] acute respiratory syndrome adenoviral vector vaccine Adults age antibodies, neutralizing approval booster vaccination Clinical efficacy Concentration coronavirus coronavirus disease Course declined English Europe groups heterogeneous Hospitalization immunogenicity immunogenicity, vaccine increase Infection mRNA vaccines National neutralizing antibody New Older omicron original virus strain Patient recommendation recommendations reduced risk Risk factors SARS-CoV‑2 SARS-CoV‑2 variants severe disease tested Trial Vaccination recommendations. Vaccinations Vaccine vaccine dose Vaccines variant viral evolution virus variant virus variants
[DOI] 10.1007/s00391-022-02102-x PMC 바로가기